UK - GlaxoSmithKline has officially "postponed" a proposal to increase the value of its chief executive remuneration package by £7.5m.
The decision was taken after discussions with shareholders opposed to long-term incentive awards for Jean-Pierre Garnier. A statement from the pharmaceutical giant said: “After taking account of...
To continue reading this article...
Join Professional Pensions
Become a Professional Pensions Lite Member today
- Three complimentary articles per month covering the latest real-time news, analysis and opinion from the industry
- Receive important and breaking news stories via our two daily news alerts
- Hear from industry experts and other forward-thinking leaders